Dataset Information


Marked Disparity of MicroRNA Modulation by cGMP-selective PDE5 versus PDE9 Inhibitors in Heart Disease

ABSTRACT: This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

INSTRUMENT(S): Illumina HiSeq 2500 (Mus musculus)

SUBMITTER: Kristen Kokkonen-Simon 

PROVIDER: GSE112056 | GEO | 2018-08-09



altmetric image


Marked disparity of microRNA modulation by cGMP-selective PDE5 versus PDE9 inhibitors in heart disease.

Kokkonen-Simon Kristen M KM   Saberi Amir A   Nakamura Taishi T   Ranek Mark J MJ   Zhu Guangshuo G   Bedja Djahida D   Kuhn Michaela M   Halushka Marc K MK   Lee Dong Ik DI   Kass David A DA  

JCI insight 20180809 15

MicroRNAs (miRs) posttranscriptionally regulate mRNA and its translation into protein, and are considered master controllers of genes modulating normal physiology and disease. There is growing interest in how miRs change with drug treatment, and leveraging this for precision guided therapy. Here we contrast 2 closely related therapies, inhibitors of phosphodiesterase type 5 or type 9 (PDE5-I, PDE9-I), given to mice subjected to sustained cardiac pressure overload (PO). Both inhibitors augment cy  ...[more]

Similar Datasets

2018-01-01 | S-EPMC6129132 | BioStudies
| PRJNA439190 | ENA
2012-01-01 | S-EPMC3262907 | BioStudies
2016-08-20 | E-GEOD-85728 | BioStudies
2013-01-22 | E-GEOD-43179 | BioStudies
2013-08-30 | E-GEOD-43900 | BioStudies
2013-04-04 | E-GEOD-45754 | BioStudies
2014-07-03 | E-GEOD-51858 | BioStudies
2009-01-01 | S-EPMC3172082 | BioStudies
2013-10-01 | E-GEOD-51296 | BioStudies